6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

37 trials found

diseases per page:

Showing 1 to 10 of 37 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05610189 (ClinicalTrials.gov)	December 15, 2022	2/11/2022	Multiple-dose Trial to Determine the Clinical Bioequivalence Between TavapadonTablets in Participant ...	A Phase 1, Randomized, Multiple-dose, Crossover Trial in Participants With Parkinson's Disease to Ev ...	Parkinson Disease	Drug: Tavapadon	Cerevel Therapeutics, LLC	NULL	Recruiting	45 Years	80 Years	All	24	Phase 1	United States
2	NCT05581823 (ClinicalTrials.gov)	October 19, 2022	12/10/2022	Study to Evaluate the Effects of Cytochrome P450 (CYP) 3A4 Inducer Carbamazepine on TavapadonPharmac ...	A Phase 1, Open-label, Fixed-sequence, Crossover Trial to Evaluate the Effects of Cytochrome P450 (C ...	Parkinson Disease	Drug: Tavapadon;Drug: Carbamazepine	Cerevel Therapeutics, LLC	NULL	Active, not recruiting	18 Years	55 Years	All	16	Phase 1	United States
3	EUCTR2019-002952-17-BG (EUCTR)	31/05/2021	21/05/2021	A clinical trial which runs in multiple countries and aims to evaluate the long-term safety and tole ...	58-Week Open-label Trial of Tavapadon in Parkinson’s Disease (TEMPO-4 Trial) - TEMPO-4	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease MedDRA version: 20.0;Level: ...	Product Name: Tavapadon Product Code: CVL-751 INN or Proposed INN: TAVAPADON Other descriptive name: PF ...	Cerevel Therapeutics, LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	854	Phase 3	Serbia;United States;Czechia;Spain;Ukraine;Israel;Italy;France;Czech Republic;Hungary;Canada;Poland; ...
4	EUCTR2019-002952-17-DE (EUCTR)	30/03/2021	18/09/2020	A clinical trial which runs in multiple countries and aims to evaluate the long-term safety and tole ...	58-Week Open-label Trial of Tavapadon in Parkinson’s Disease (TEMPO-4 Trial) - TEMPO-4	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease MedDRA version: 20.0;Level: ...	Product Name: Tavapadon Product Code: CVL-751 INN or Proposed INN: TAVAPADON Other descriptive name: PF ...	Cerevel Therapeutics, LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	854	Phase 3	Serbia;United States;Czechia;Spain;Ukraine;Israel;Italy;France;Hungary;Canada;Poland;Australia;Bulga ...
5	NCT04760769 (ClinicalTrials.gov)	February 24, 2021	12/2/2021	Open-label Trial in Parkinson's Disease (PD)	58-Week Open-label Trial of Tavapadon in Parkinson's Disease (TEMPO-4 Trial)	Parkinson Disease	Drug: Tavapadon	Cerevel Therapeutics, LLC	NULL	Enrolling by invitation	40 Years	80 Years	All	800	Phase 3	United States;Australia;Bulgaria;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Poland;Serbia;Sp ...
6	EUCTR2019-002952-17-IT (EUCTR)	19/02/2021	25/01/2021	A clinical trial which runs in multiple countries and aims to evaluate the long-term safety and tole ...	58-Week Open-label Trial of Tavapadon in Parkinson's Disease (TEMPO-4Trial) - TEMPO-4	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease MedDRA version: 20.0;Level: ...	Product Name: Tavapadon 5 mg Product Code: [CVL-751] INN or Proposed INN: TAVAPADON Other descriptive na ...	Cerevel Therapeutics LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	854	Phase 3	Serbia;United States;Czechia;Spain;Ukraine;Israel;Italy;France;Czech Republic;Hungary;Canada;Poland; ...
7	EUCTR2019-002949-38-BG (EUCTR)	13/01/2021	21/12/2020	A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, PARALLEL GROUP, 27 WEEK TRIAL TO EVALUATE T ...	A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, PARALLEL GROUP, 27 WEEK TRIAL TO EVALUATE T ...	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease MedDRA version: 20.0;Level: ...	Product Name: Tavapadon 0.25mg Product Code: CVL-751 INN or Proposed INN: TAVAPADON Other descriptive na ...	Cerevel Therapeutics, LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	522	Phase 3	United States;Czechia;Spain;Ukraine;Israel;Italy;France;Czech Republic;Hungary;Canada;Poland;Austral ...
8	EUCTR2019-002951-40-BG (EUCTR)	11/01/2021	05/01/2021	A clinical trial which runs in multiple countries and aims to analyse how efficient, safe and tolera ...	A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Flexible-Dose, 27-Week Tria ...	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease with Motor Fluctuations MedD ...	Product Name: Tavapadon 5mg Product Code: CVL-751 INN or Proposed INN: TAVAPADON Other descriptive name: ...	Cerevel Therapeutics, LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	368	Phase 3	Serbia;United States;Czechia;Spain;Ukraine;Israel;Italy;France;Czech Republic;Hungary;Canada;Poland; ...
9	EUCTR2019-002952-17-HU (EUCTR)	30/12/2020	19/10/2020	A clinical trial which runs in multiple countries and aims to evaluate the long-term safety and tole ...	58-Week Open-label Trial of Tavapadon in Parkinson’s Disease (TEMPO-4 Trial) - TEMPO-4	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease MedDRA version: 20.0;Level: ...	Product Name: Tavapadon 5mg Product Code: CVL-751 INN or Proposed INN: TAVAPADON Other descriptive name: ...	Cerevel Therapeutics, LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	854	Phase 3	United States;Serbia;Spain;Ukraine;Israel;Italy;France;Hungary;Czech Republic;Canada;Poland;Australi ...
10	EUCTR2019-002952-17-CZ (EUCTR)	04/11/2020	12/10/2020	A clinical trial which runs in multiple countries and aims to evaluate the long-term safety and tole ...	58-Week Open-label Trial of Tavapadon in Parkinson’s Disease (TEMPO-4 Trial) - TEMPO-4	Patients (40 to 80 years age) who have diagnosis of Parkinson's Disease MedDRA version: 20.0;Level: ...	Product Name: Tavapadon Product Code: CVL-751 INN or Proposed INN: TAVAPADON Other descriptive name: PF ...	Cerevel Therapeutics, LLC	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	854	Phase 3	Serbia;United States;Czechia;Spain;Ukraine;Israel;Italy;France;Czech Republic;Hungary;Canada;Poland; ...

First Previous1 2 3 4Next Last